Global Peptide Vaccine Market Research Report 2024(Status and Outlook)

Global Peptide Vaccine Market Research Report 2024(Status and Outlook)



Report Overview:

Peptide vaccines include one or more short or long amino acids sequences, as an antigen combined with a vaccine adjuvant. Thus they fall in the broad category of defined antigen vaccines, along with the vaccines using proteins, protein sub units, DNA and RNA. They remain the most immunogenic approaches based on the measures of T-cell responses. Peptide immunogenicity is influenced by the way in which peptides are presented to the immune system, underscoring the need for multifunctional delivery systems that couple antigen and adjuvant into a single construct.

The Global Peptide Vaccine Market Size was estimated at USD 3842.05 million in 2023 and is projected to reach USD 4946.17 million by 2029, exhibiting a CAGR of 4.30% during the forecast period.

This report provides a deep insight into the global Peptide Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Peptide Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Peptide Vaccine market in any manner.

Global Peptide Vaccine Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Anergis

Antigen Express

Apitope Technology

Artificial Cell Technologies

Benovus Bio

Celgene Corporation

Immatics biotechnologies

Merck

ImmunoCellular Therapeutics

ISA Pharmaceuticals

Lytix Biopharma

Spotlight Innovation

OncoTherapy Science

Peptech

Pharmasyntez

Sumitomo Dainippon Pharma

TapImmune

Targovax

Market Segmentation (by Type)

Solution Phase Synthesis (SPS)

Solid Phase Peptide Synthesis (SPPS)

Market Segmentation (by Application)

Prostate Cancer

Breast Cancer

Gastric Cancer

Lung Cancer

Pancreatic Cancer

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Peptide Vaccine Market

Overview of the regional outlook of the Peptide Vaccine Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Peptide Vaccine Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Peptide Vaccine
1.2 Key Market Segments
1.2.1 Peptide Vaccine Segment by Type
1.2.2 Peptide Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Peptide Vaccine Market Overview
2.1 Global Market Overview
2.1.1 Global Peptide Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Peptide Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Peptide Vaccine Market Competitive Landscape
3.1 Global Peptide Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Peptide Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Peptide Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Peptide Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Peptide Vaccine Sales Sites, Area Served, Product Type
3.6 Peptide Vaccine Market Competitive Situation and Trends
3.6.1 Peptide Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Peptide Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Peptide Vaccine Industry Chain Analysis
4.1 Peptide Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Peptide Vaccine Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Peptide Vaccine Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Peptide Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Peptide Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Peptide Vaccine Price by Type (2019-2024)
7 Peptide Vaccine Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Peptide Vaccine Market Sales by Application (2019-2024)
7.3 Global Peptide Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Peptide Vaccine Sales Growth Rate by Application (2019-2024)
8 Peptide Vaccine Market Segmentation by Region
8.1 Global Peptide Vaccine Sales by Region
8.1.1 Global Peptide Vaccine Sales by Region
8.1.2 Global Peptide Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Peptide Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Peptide Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Peptide Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Peptide Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Peptide Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Anergis
9.1.1 Anergis Peptide Vaccine Basic Information
9.1.2 Anergis Peptide Vaccine Product Overview
9.1.3 Anergis Peptide Vaccine Product Market Performance
9.1.4 Anergis Business Overview
9.1.5 Anergis Peptide Vaccine SWOT Analysis
9.1.6 Anergis Recent Developments
9.2 Antigen Express
9.2.1 Antigen Express Peptide Vaccine Basic Information
9.2.2 Antigen Express Peptide Vaccine Product Overview
9.2.3 Antigen Express Peptide Vaccine Product Market Performance
9.2.4 Antigen Express Business Overview
9.2.5 Antigen Express Peptide Vaccine SWOT Analysis
9.2.6 Antigen Express Recent Developments
9.3 Apitope Technology
9.3.1 Apitope Technology Peptide Vaccine Basic Information
9.3.2 Apitope Technology Peptide Vaccine Product Overview
9.3.3 Apitope Technology Peptide Vaccine Product Market Performance
9.3.4 Apitope Technology Peptide Vaccine SWOT Analysis
9.3.5 Apitope Technology Business Overview
9.3.6 Apitope Technology Recent Developments
9.4 Artificial Cell Technologies
9.4.1 Artificial Cell Technologies Peptide Vaccine Basic Information
9.4.2 Artificial Cell Technologies Peptide Vaccine Product Overview
9.4.3 Artificial Cell Technologies Peptide Vaccine Product Market Performance
9.4.4 Artificial Cell Technologies Business Overview
9.4.5 Artificial Cell Technologies Recent Developments
9.5 Benovus Bio
9.5.1 Benovus Bio Peptide Vaccine Basic Information
9.5.2 Benovus Bio Peptide Vaccine Product Overview
9.5.3 Benovus Bio Peptide Vaccine Product Market Performance
9.5.4 Benovus Bio Business Overview
9.5.5 Benovus Bio Recent Developments
9.6 Celgene Corporation
9.6.1 Celgene Corporation Peptide Vaccine Basic Information
9.6.2 Celgene Corporation Peptide Vaccine Product Overview
9.6.3 Celgene Corporation Peptide Vaccine Product Market Performance
9.6.4 Celgene Corporation Business Overview
9.6.5 Celgene Corporation Recent Developments
9.7 Immatics biotechnologies
9.7.1 Immatics biotechnologies Peptide Vaccine Basic Information
9.7.2 Immatics biotechnologies Peptide Vaccine Product Overview
9.7.3 Immatics biotechnologies Peptide Vaccine Product Market Performance
9.7.4 Immatics biotechnologies Business Overview
9.7.5 Immatics biotechnologies Recent Developments
9.8 Merck
9.8.1 Merck Peptide Vaccine Basic Information
9.8.2 Merck Peptide Vaccine Product Overview
9.8.3 Merck Peptide Vaccine Product Market Performance
9.8.4 Merck Business Overview
9.8.5 Merck Recent Developments
9.9 ImmunoCellular Therapeutics
9.9.1 ImmunoCellular Therapeutics Peptide Vaccine Basic Information
9.9.2 ImmunoCellular Therapeutics Peptide Vaccine Product Overview
9.9.3 ImmunoCellular Therapeutics Peptide Vaccine Product Market Performance
9.9.4 ImmunoCellular Therapeutics Business Overview
9.9.5 ImmunoCellular Therapeutics Recent Developments
9.10 ISA Pharmaceuticals
9.10.1 ISA Pharmaceuticals Peptide Vaccine Basic Information
9.10.2 ISA Pharmaceuticals Peptide Vaccine Product Overview
9.10.3 ISA Pharmaceuticals Peptide Vaccine Product Market Performance
9.10.4 ISA Pharmaceuticals Business Overview
9.10.5 ISA Pharmaceuticals Recent Developments
9.11 Lytix Biopharma
9.11.1 Lytix Biopharma Peptide Vaccine Basic Information
9.11.2 Lytix Biopharma Peptide Vaccine Product Overview
9.11.3 Lytix Biopharma Peptide Vaccine Product Market Performance
9.11.4 Lytix Biopharma Business Overview
9.11.5 Lytix Biopharma Recent Developments
9.12 Spotlight Innovation
9.12.1 Spotlight Innovation Peptide Vaccine Basic Information
9.12.2 Spotlight Innovation Peptide Vaccine Product Overview
9.12.3 Spotlight Innovation Peptide Vaccine Product Market Performance
9.12.4 Spotlight Innovation Business Overview
9.12.5 Spotlight Innovation Recent Developments
9.13 OncoTherapy Science
9.13.1 OncoTherapy Science Peptide Vaccine Basic Information
9.13.2 OncoTherapy Science Peptide Vaccine Product Overview
9.13.3 OncoTherapy Science Peptide Vaccine Product Market Performance
9.13.4 OncoTherapy Science Business Overview
9.13.5 OncoTherapy Science Recent Developments
9.14 Peptech
9.14.1 Peptech Peptide Vaccine Basic Information
9.14.2 Peptech Peptide Vaccine Product Overview
9.14.3 Peptech Peptide Vaccine Product Market Performance
9.14.4 Peptech Business Overview
9.14.5 Peptech Recent Developments
9.15 Pharmasyntez
9.15.1 Pharmasyntez Peptide Vaccine Basic Information
9.15.2 Pharmasyntez Peptide Vaccine Product Overview
9.15.3 Pharmasyntez Peptide Vaccine Product Market Performance
9.15.4 Pharmasyntez Business Overview
9.15.5 Pharmasyntez Recent Developments
9.16 Sumitomo Dainippon Pharma
9.16.1 Sumitomo Dainippon Pharma Peptide Vaccine Basic Information
9.16.2 Sumitomo Dainippon Pharma Peptide Vaccine Product Overview
9.16.3 Sumitomo Dainippon Pharma Peptide Vaccine Product Market Performance
9.16.4 Sumitomo Dainippon Pharma Business Overview
9.16.5 Sumitomo Dainippon Pharma Recent Developments
9.17 TapImmune
9.17.1 TapImmune Peptide Vaccine Basic Information
9.17.2 TapImmune Peptide Vaccine Product Overview
9.17.3 TapImmune Peptide Vaccine Product Market Performance
9.17.4 TapImmune Business Overview
9.17.5 TapImmune Recent Developments
9.18 Targovax
9.18.1 Targovax Peptide Vaccine Basic Information
9.18.2 Targovax Peptide Vaccine Product Overview
9.18.3 Targovax Peptide Vaccine Product Market Performance
9.18.4 Targovax Business Overview
9.18.5 Targovax Recent Developments
10 Peptide Vaccine Market Forecast by Region
10.1 Global Peptide Vaccine Market Size Forecast
10.2 Global Peptide Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Peptide Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Peptide Vaccine Market Size Forecast by Region
10.2.4 South America Peptide Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Peptide Vaccine by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Peptide Vaccine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Peptide Vaccine by Type (2025-2030)
11.1.2 Global Peptide Vaccine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Peptide Vaccine by Type (2025-2030)
11.2 Global Peptide Vaccine Market Forecast by Application (2025-2030)
11.2.1 Global Peptide Vaccine Sales (Kilotons) Forecast by Application
11.2.2 Global Peptide Vaccine Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings